
23.74 Delayed Data As of Mar 20 | ![]() Today’s Change | 13.92 Today|||52-Week Range 28.18 | +63.61% Year-to-Date |
SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $1.9B |
Myriad Genetics, Inc. 320 Wakara Way Salt Lake City Utah 84108 |
Paul J. Diaz | President, Chief Executive Officer & Director |
Nicole Lambert | Chief Operating Officer |
R. Bryan Riggsbee | Chief Financial Officer, Treasurer & Executive VP |
Dale Muzzey | Chief Scientific Officer |
Kevin R. Haas | Chief Technology Officer |